Merit Medical (MMSI) CCO granted stock awards and surrenders shares for taxes

Rhea-AI Filing Summary

Merit Medical Systems’ Chief Commercial Officer Christian Adam Smith reported multiple equity awards and related tax withholding in company stock. On February 26, 2026, he acquired 8,203, 6,409 and 6,762 shares of common stock at $0 per share through grants and the settlement of performance stock units.

Footnotes state two awards are restricted stock units that vest in scheduled annual installments over two or three years, each RSU converting into one share upon vesting. An additional 2,018 shares were surrendered back to the company at $78.02 per share to cover payroll and income taxes, with no shares sold in the open market.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Smith Christian Adam

(Last) (First) (Middle)

1600 W MERIT PARKWAY

(Street)

SOUTH JORDAN UT 84095

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
MERIT MEDICAL SYSTEMS INC [ MMSI ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Commercial Officer

3. Date of Earliest Transaction (Month/Day/Year)
02/26/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock, No Par Value								598	I	By 401(k) Plan(1)
Common Stock, No Par Value	02/26/2026		A		8,203(2)	A	$0	19,181	D
Common Stock, No Par Value	02/26/2026		A		6,409(3)	A	$0	25,590	D
Common Stock, No Par Value	02/26/2026		A		6,762(4)	A	$0	32,352	D
Common Stock, No Par Value	02/26/2026		F		2,018(5)	D	$78.02	30,334	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Non-qualified stock options (right to buy)	$70.5							10/04/2022(6)	10/04/2028	Common Stock	25,000		25,000	D
Non-qualified stock options (right to buy)	$73.95							03/31/2024(7)	03/31/2030	Common Stock	8,259		8,259	D

Explanation of Responses:

1. Represents plan holdings as of 02/26/2026.

2. Represents a grant of restricted stock units ("RSUs"). The RSUs vest in three equal annual installments on each of the first three anniversaries of the grant date, subject to the Reporting Person's continued service through the applicable vesting date. Each RSU represents the contingent right to receive one share of Common Stock upon vesting.

3. Represents a grant of RSUs. The RSUs vest in two equal installments on each of the second and the third anniversaries of the grant date, subject to the Reporting Person's continued service through the applicable vesting date. Each RSU represents the contingent right to receive one share of Common Stock upon vesting.

4. These shares were acquired upon a determination of the Company's Compensation and Talent Development Committee that certain conditions had been met for the issuance of such shares pursuant to performance stock units that were granted on 03/31/2023.

5. The Reporting Person surrendered 2,018 shares of common stock to the Issuer for payroll and income taxes. No shares were sold in the open market.

6. Become exercisable in equal annual installments of 25% commencing on 10/4/2022.

7. Become exercisable in equal annual installments of 25% commencing on 3/31/2024.

	/s/ Brian G. Lloyd, Attorney-in-Fact	03/02/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What equity awards did MMSI’s Chief Commercial Officer receive on February 26, 2026?

On February 26, 2026, MMSI’s Chief Commercial Officer Christian Adam Smith received several stock awards totaling multiple thousands of shares. These included time-based restricted stock units and shares issued upon performance stock units vesting, each representing the right to receive one common share on vesting.

How do the new MMSI restricted stock units for the CCO vest?

The new MMSI restricted stock units vest in scheduled installments over multiple years. One grant vests in three equal annual installments on each of the first three anniversaries, while another vests in two equal installments on the second and third anniversaries, assuming continued service through each vesting date.

Were any MMSI shares sold on the open market in this Form 4?

No open market sales occurred in this Form 4. A footnote explains that 2,018 shares were surrendered back to Merit Medical Systems solely to satisfy payroll and income tax obligations related to equity awards, rather than being sold on a stock exchange.

What is the significance of the performance stock units mentioned for MMSI’s CCO?

Certain shares were issued after the compensation committee determined conditions were met for performance stock units granted on March 31, 2023. This means predefined performance goals were achieved, triggering the issuance of common shares to the Chief Commercial Officer under that prior performance-based award.

Does the MMSI Form 4 show option holdings for the Chief Commercial Officer?

Yes, the Form 4 lists non-qualified stock options held by the Chief Commercial Officer. Footnotes indicate these options become exercisable in equal 25% annual installments beginning on specified prior dates, reflecting a multi-year vesting schedule for the right to buy additional common shares.